The variety of possible presentations of myocardial infarction is well known, but chest pain is perhaps the most constant of symptoms. Evidence has linked duration of pain with size of infarct,' and Mitchell suggested that analgesic requirements should be used as an early guide to whether infarction has taken place.' I carried out a study to evaluate the diagnostic potential of analgesic requirements.
Suspected myocardial infarction: early diagnostic value of analgesic requirements
The variety of possible presentations of myocardial infarction is well known, but chest pain is perhaps the most constant of symptoms. Evidence has linked duration of pain with size of infarct,' and Mitchell suggested that analgesic requirements should be used as an early guide to whether infarction has taken place.' I carried out a study to evaluate the diagnostic potential of analgesic requirements.
Patients, methods, and results
Altogether, 217 consecutive admissions to the coronary care unit were considered for study. Reasons for exclusion (97 patients) included rapid death, muscular trauma, and chest pain apparently not due to myocardial ischaemia. Analgesia was given as intravenous diamorphine, usually after a trial of glyceryl trinitrate 0-5-1-0 mg sublingually.
Infarction was assumed (80 patients) if the criteria of Rowley and Hampton for definite or probable myocardial infarction were fulfilled.3 The remaining patients were assumed not to have had myocardial infarction, and 40 were included in the study. Infarct size was estimated by plasma creatine kinase activity (highest of four estimations in three days), hydroxybutyrate dehydrogenase activity (highest of three estimations), and the number of electrocardiographic territories (inferior, anterior, lateral, posterior, or The time after admission of the final injection was the most useful variable: only one (250°,,) of the group without myocardial infarction required analgesia after two hours compared with half of the group with infarction. Values in patients with equivocal electrocardiographic changes and in the one or two territory groups were 5-7, 7-6, and 13-3 hours respectively; the correlation with creatine kinase activity was r= 0 40 (p < 0 001).
Comment
The results of this study were consistent with a relation between severity of myocardial infarction and amount of analgesia required in the first hospital day. One fifth of the patients with myocardial infarction, however, did not need any analgesia at all, and one patient without myocardial infarction required 20 mg diamnorphine. Moreover, there seems little clinical advantage in attempting to guess the size of myocardial infarction after only 24 hours. In the early decision of whether infarction has taken place analgesic requirements may be of greater value. This study suggests that if a second injection of analgesia is required in the first 24 hours the chances of myocardial infarction being excluded lengthen to one in eight and myocardial infarction is four times more likely. If three or more injections are needed myocardial infarction is 10 times more likely. If a second injection is required more than three hours after admission exclusion of myocardial infarction becomes a 40 to one chance and infarction is 20 times more likely. Thus if this three hour rule was applied it would indicate infarction with a specificity of 97 5%, and a similar predictive value. A negative result is less reliable, the sensitivity being 50%/ These results confirm that analgesic requirement can be related to the size of myocardial infarction, but the clinical value of this is doubtful. Analgesic requirement can also be used as an early guide to the presence or absence of myocardial infarction. The duration of symptoms seems to be the most important factor, and if further analgesia is required after three hours in hospital this is highly suggestive of infarction. The kaolin cephalin clotting time was within the therapeutic range on 45 days, above it on 51, and below it on 84. Patients received heparin for a median of four days, and the kaolin cephalin clotting time was within the therapeutic range for a median of one day in each patient (though never in 13 patients) ( Doctors ignored 26% of all the measurements of kaolin cephalin clotting time that required a change in heparin infusion rate and changed the infusion rate in the wrong direction in 12%. Although in the right direction, 850% of the remaining changes failed to achieve a therapeutic kaolin cephalin clotting time. The therapeutic range was achieved on 27% of the days by infusion pump and on 19% of the days by burette (p >0 05). The mean (SD) infusion rate required to achieve a therapeutic kaolin cephalin clotting time of 60 seconds was 1404 (432) U/h (n=28, range 690-2500 U/h) (1513 (417) U/h in men and 1278 (429) U/h in women (p >0 05)). There was no significant relation between the therapeutic infusion rate and the age or weight of the patient.
Heparin control in our hospital is poor, with 260' of kaolin cephalin clotting times being ignored, 12%o of responses being made in the wrong direction, and a high degree of inaccuracv in remaining responses. Accurate control is complicated by two other factors: firstly, there is wide interpatient variation in drug clearance and responses of the kaolin cephalin clotting time to given plasma heparin concentrations3; and, secondly, the response to heparin is not linear, so that a given increment in the heparin infusion rate will not result in a proportionate increment in the kaolin cephalin clotting time. ' Heparin should be delivered by infusion as this avoids potentially dangerous peaks of heparin activity (and correspondingly greater risk of haemorrhage) that sometimes occur after bolus injections.5
Although we expected infusion pumps to maintain a steadier rate of infusion than burettes operated by nurses, the difference in control was not significant, and so other factors must also affect control.
If the concept of a therapeutic range of kaolin cephalin clotting time is accepted more attention should be paid to it when controlling treatment with heparin, a potentially dangerous drug. As the kaolin cephalin clotting time approaches the therapeutic range lower increments in the heparin infusion rate should be made to achieve equivalent increments in the kaolin cephalin clotting time. Individual titration of the infusion rate is necessary to optimise efficiency and reduce potential toxicity. Long and short kaolin cephalin clotting times should not be ignored.
We thank the consultant staff of Llandough Hospital for allowing us to use their patients for this study. Why do people seek treatment by alternative medicine?
Interest in complementary medicine is clearly increasing,' 2 but no one has asked the general public why they seek such treatment. We carried out a study at the Centre for Alternative Therapies to evaluate the characteristics of patients seeking treatment. The scope of their presenting problems, the reasons why patients elect to be treated by complementary medicine, patients' knowledge, attitudes, and expectations about such treatment, and the efficacy of these methods in pain and depression were assessed. The centre is private, although 20°" of patients are classed as socially disadvantaged and are seen either free of charge or for a small fee. The services offered include acupuncture, manipulative medicine, homoeopathy, clinical ecology, biofeedback, psychotherapy, the Alexander technique, and hypnosis.
Patients, methods, and results
We compiled a questionnaire to evaluate our aims after several open recorded interviews with patients. The questionnaire was given to all 65 new patients seen at the centre over four weeks. Twenty minute interviews took place after the patients had seen one of the doctors. Eight weeks after the first interview a follow up questionnaire was issued, and strenuous efforts were made to ensure maximum response. 
Comment
Patients seen at the centre were not "cranks" and had not lost confidence in conventional medicine. They were well informed and seeking a solution to unresolved long term problems. Our study showed that 59"0 of patients attending the centre felt much better after eight weeks' treatment. Further studies should be directed at exploring the reasons for the increase in provision of alternative
